Inside Wall Street’s ‘SRT’ phenomenon
Every so often a cool new financial innovation springs up and gains popularity on Wall Street, promising juicy returns for investors. That’s why “synthetic risk transfers” or SRTs are in fashion. But ever since the financial crisis, trendy acronyms have also made some people nervous. And it’s recently caught the attention of organisations such as the IMF.
» Read more about: Inside Wall Street’s ‘SRT’ phenomenon »
Read More3 Top Quantum Stocks to Buy
The last several years have seen a series of tech cycles drive up the stock market. From Metaverse technology to the rise of generative AI, everyone from retail investors to hedge fund managers is looking to get in on the next huge tech development.
Going into 2025, it appears that the technology to go long on may be quantum computing.
» Read more about: 3 Top Quantum Stocks to Buy »
Read MoreWill gold lose sheen in 2025?
Gold rewarded both investors and central banks in 2024. The economic pressures of three independent wars across the globe,
» Read more about: Will gold lose sheen in 2025? »
Read MoreCME Bitcoin Options at Most Bullish Since U.S. Election, ETF Inflows Surge
Bullish options pricing and renewed ETF inflows have analysts calling new highs for the largest cryptocurrency.
» Read more about: CME Bitcoin Options at Most Bullish Since U.S. Election, ETF Inflows Surge »
Read MoreHow will CD interest rates be impacted by the January Fed meeting?
If you were looking for a safe way to boost and protect your money in the inflationary economic cycle of recent years,
» Read more about: How will CD interest rates be impacted by the January Fed meeting? »
Read MoreThe Burst
Why This Buffett Stock Is a Forever Buy
Among Warren Buffett’s favorite investments is Coca-Cola, a Dividend King that has raised its dividend annually for a remarkable 62 consecutive years. This track record puts Coca-Cola in the elite club of dividend-paying stocks that have increased their dividends annually for at least 50 years.
Such consistent dividend hikes not only help investors to combat inflation but also substantially compound their returns.
» Read more about: Why This Buffett Stock Is a Forever Buy »
Read MoreThe Ivy
Is Crowdstrike a Risky Buy or a Golden Opportunity?
Crowdstrike at this moment in time is the epitome of what makes investing challenging. The blackout experienced around the world due to an error in code left the reputation of the cybersecurity firm in tatters.
The company now faces two major hurdles to win back customer confidence. First, it has to win back the confidence of its clients and secondly it has to resolve the liabilities that may follow the global outage.
» Read more about: Is Crowdstrike a Risky Buy or a Golden Opportunity? »
Read MoreThe Spotlight
Spotlight: 1 Heart Transplant Stock Up Over 500%
TransMedics (NASDAQ:TMDX) has emerged as a prominent player in the medical field, witnessing a remarkable surge from $14 to $90 in a little over 18 months.
The company’s core expertise lies in organ care systems, which preserve transplant organs post-donor retrieval.